s6y
Company name or ticker
Search
CytomX Therapeutics, Inc.
8-K
Director or officer change
Filed
Tuesday, October 24, 2017
Period
Oct 23, 2017
Accession number
0001564590-17-019886
Documents
Current report filing
8-K
99.1
Press release or other material
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header